Terns Pharmaceuticals (TERN)

• Market cap: $3.72B
• 1 day: -0.18%
• 5 days: -4.76%
• 1 month: -17.59%
• 3 months: 326.43%
• 6 months: 494.78%
• Year to date: -14.73%
• 1 year: 718.18%
• 5 years: 85.97%
• 10 years: 85.97%
• Sector: Healthcare
• Industry: Biotechnology

About: Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases. Its product candidates include TERN-701, TERN-601, TERN-501 and TERN-800.

Employees: 59